• Please log in or register to access this feature.

Original Article

You have full text access to this OnlineOpen article

Hepatic sinusoidal fibrosis induced by cholesterol and stilbestrol in the rabbit: 1. Morphology and inhibition of fibrogenesis by dipyridamole

  1. I R Wanless,
  2. J Belgiorno,
  3. P Huet

Article first published online: 30 DEC 2003

DOI: 10.1002/hep.510240417

Issue

Hepatology

Hepatology

Volume 24, Issue 4, pages 855–864, October 1996

Additional Information

How to Cite

Wanless, I. R., Belgiorno, J. and Huet, P. (1996), Hepatic sinusoidal fibrosis induced by cholesterol and stilbestrol in the rabbit: 1. Morphology and inhibition of fibrogenesis by dipyridamole. Hepatology, 24: 855–864. doi: 10.1002/hep.510240417

Author Information

  1. Department of Pathology, The Toronto Hospital, University of Toronto, Ontario, Canada

Publication History

  1. Issue published online: 30 DEC 2003
  2. Article first published online: 30 DEC 2003

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

Get PDF (3437K)

References

  • 1
    Bullock BC, Paula R, Rudel LL. Dietary-induced cirrhosis in the pig-tailed macaque (Macaca nemestrina). Fed Proc 1974; 33: 626.
  • 2
    Lee SS, Ho KJ. Cholesterol fatty liver. Morphological changes in the course of its development in rabbits. Arch Pathol 1975; 99: 301–306.
  • 3
    Gupta PP, Tandon HD, Ramalingaswami V. Cirrhosis of the liver in rabbits induced by a high cholesterol diet—an experimental model. Indian J Med Res 1976; 64: 1516–1526.
  • 4
    Ronnemaa T. Effect of high cholesterol, olive oil diet on the lipids and connective tissue in rat liver. A biochemical study. Scand J Gastroenterol 1976; 11: 849–855.
  • 5
    Temmerman AM, Vonk RJ, Niezen-Koning K, Berger R, Fernandes J. Long-term and short-term effects of dietary cholesterol and fats in the Mongolian gerbil. Ann Nutr Metab 1988; 32: 177–185.
  • 6
    Constantinides P, Gutmann-Auersperg N. Inhibition of progress of prees-tablished atherosclerosis by diethylstilbestrol in the rabbit. Arch Pathol 1960; 70: 35–42.
  • 7
    Numano F, Katsu K, Kitta T, Shimamoto T. Banti-like syndrome induced by estrogen and cholesterol. Acta Hepatosplenol 1969; 16: 77–85.
  • 8
    Skjaerlund JM. Estrogen protection against atherosclerosis and synthetic estrogen production of cirrhosis in the rabbit. Res Commun Chem Pathol Pharmacol 1992; 75: 193–208.
  • 9
    Joist JH, Dolezel G, Kinlough-Rathbone R, Mustard JF. Effect of diet-induced hyperlipidemia on in vitro function of rabbit platelets. Thromb Res 1976; 9: 435–445.
  • 10
    Peters JR, Elliott JM, Grahame-Smith DG. Effect of oral contraceptives on platelet noradrenaline and 5-hydroxytryptamine receptors and aggregation. Lancet 1979; 2: 933–936.
  • 11
    Stuart MJ, Gerrard JM, White JG. Effect of cholesterol on production of thromboxane B2 by platelets in vitro. N Engl J Med 1980; 302: 6–10.
  • 12
    Anonymous. The coronary drug project: initial findings leading to modifications of its research protocol. JAMA 1970; 214: 1303–1313.
  • 13
    Suehiro A, Kakishita E, Nagai K. The role of platelet hyperfunction in thrombus formation in hyperlipidemia. Thromb Res 1982; 25: 331–339.
  • 14
    Bremme K, Wramsby H, Andersson O, Wallin M, Blomback M. Do lowered factor VII levels at extremely high endogenous oestradiol levels protect against thrombin formation? Blood Coagul Fibrinolysis 1994; 5: 205–210.
  • 15
    Pinzani M, Gesualdo L, Sabbah GM, Abboud HE. Effects of platelet-derived growth factor and other polypeptide mitogens on DNA synthesis and growth of cultured rat liver fat-storing cells. J Clin Invest 1989; 84: 1786–1793.
  • 16
    Friedman SL. The cellular basis of hepatic fibrosis. N Engl J Med 1993; 328: 1828–1835.
  • 17
    Peterson TC, Isbrucker RA, Hooper ML. In vitro effect of platelet-derived growth factor on fibroproliferation and effect of cytokine antagonists. Immunopharmacology 1994; 28: 259–270.
  • 18
    Wybenga DR, Pileggi VJ, Dirstine PH, DiGiorgio J. Direct manual determination of serum total cholesterol with a single stable reagent. Clin Chem 1970; 16: 980–984.
  • 19
    Schwarz HP, Bergman K, Paumgartner G. A simple method for the estimation of bile acids in serum. Clin Chim Acta 1974; 50: 197–206.
  • 20
    Rojkind M, Gonzales E. An improved method for determining specific radioactivities of proline-14C and hydroxyproline-14C in collagen and in noncollagenous proteins. Anal Biochem 1974; 57: 1–7.
  • 21
    Gascon-Barre M, Huet PM, Belgiorno J. Estimation of collagen content of liver specimens. Variation between animals and between hepatic lobes in cirrhotic rats. J Histochem Cytochem 1989; 37: 377–381.
  • 22
    Lopez-DeLeon A, Rojkind M. A simple micromethod for collagen and total protein determination in formalin-fixed paraffin-embedded sections. J Histochem Cytochem 1985; 3: 737–743.
  • 23
    Mastai R, Laganiere S, Wanless IR, Giroux L, Rocheleau B, Huet P-M. Hepatic sinusoidal fibrosis induced by cholesterol and stilbestrol in the rabbit. 2. hemodynamic and drug disposition studies. Hepatology 1996; 24: 865–870.
    Direct Link:
  • 24
    Wilson JD. The quantification of cholesterol excretion and degradation in the isotopic steady state in the rat: the influence of dietary cholesterol. J Lipid Res 1964; 5: 409–417.
  • 25
    Hellstrom K. On the bile and neutral fecal steroid excretion in man and rabbits following cholesterol feeding. Acta Physiol Scand 1965; 63: 21–35.
    Direct Link:
  • 26
    Quintao E, Grundy SM, Ahrens EHJ. Effects of dietary cholesterol on the regulation of total body cholesterol in man. J Lipid Res 1971; 12: 233–247.
  • 27
    Forker EL. The effect of estrogen on bile formation in the rat. J Clin Invest 1969; 48: 654–663.
  • 28
    Coe JE, Ishak KG, Ross MJ. Diethylstilbestrol-induced jaundice in the Chinese and Armenian hamster. Hepatology 1983; 3: 489–496.
    Direct Link:
  • 29
    Tuchweber B, Perea A, Carrillo MC, Villalon L, Lemay J, Yousef IM. Low protein diet protects against ethinyl estradiol-induced cholestasis. Nutr Res 1994; 14: 707–716.
  • 30
    Schaffher F, Popper H. Capillarization of the hepatic sinusoids in man. Gastroenterology 1963; 4: 239–242.
  • 31
    Nanji AA, French SW. Relationship between pork consumption and cirrhosis. Lancet 1985; 1: 681–683.
  • 32
    Patek AJ, Bowry S, Hayes KC. Cirrhosis of choline deficiency in the Rhesus monkey. Possible role of cholesterol. Proc Soc Exp Biol Med 1975; 148: 370–374.
  • 33
    Hunt CE, Diani AR, Brown PK, Kaluzny MA, Epps DE. Diet induced atherogenic hyperlipoproteinaemia and liver injury in cynomolgus macaques. Br J Exp Pathol 1986; 67: 235–249.
  • 34
    Phillips MJ, Poucell S, Patterson J, Valencia P. The liver: an atlas and text of ultrastructural pathology. New York, NY: Raven, 1987.
  • 35
    Davis RA, Kern F, Showalter R, Sutherland E, Sinensky M, Simon FR. Alterations of hepatic Na, K-ATPase and bile flow by estrogen: effects on liver surface membrane lipid structure and function. Proc Natl Acad Sci USA 1978; 75: 4130–4134.
  • 36
    Sweeney GD, Cole FM. Effects of ethynyl estradiol on liver microsomal mixed function oxygenase activity in male rats. Lab Invest 1980; 42: 231–235.
  • 37
    Liehr JG, DaGue BB, Ballatore AM, Henkin J. Diethylstilbestrol (DES) quinone: a reactive intermediate in DES metabolism. Biochem Pharmacol 1983; 32: 3711–3718.
  • 38
    Peterson TC. Pentoxifylline prevents fibrosis in an animal model and inhibits platelet-derived growth factor driven proliferation of fibroblasts. Hepatology 1993; 17: 486–493.
  • 39
    Gressner AM, Bachem MG. Cellular communications and cell-matrix interactions in the pathogenesis of fibroproliferative diseases—liver fibrosis as a paradigm. Ann Biol Clin (Paris) 1994; 52: 205–226.
  • 40
    Marra F, Choudhury GG, Pinzani M, Abboud HE. Regulation of platelet-derived growth factor secretion and gene expression in human liver fatstoring cells. Gastroenterology 1994; 107: 1110–1117.
  • 41
    Lane DA, Ireland H, Wolff S, Ranasinghe E, Dawes J. Detection of enhanced in vivo platelet alpha-granule release in different patient groups. Comparison of beta-thromboglobulin, platelet factor 4 and thrombospon-din assays. Thromb Haemost 1984; 52: 183–187.
  • 42
    Hughes RD, Lane DA, Ireland H, Langley PG, Gimson AE, Williams R. Fibrinogen derivatives and platelet activation products in acute and chronic liver disease. Clin Sci 1985; 68: 701–707.
  • 43
    Goodman ZD, Ishak KG. Occlusive venous lesions in alcoholic liver disease: a study of 200 cases. Gastroenterology 1982; 83: 786–796.
  • 44
    Burt AD, MacSween RN. Hepatic vein lesions in alcoholic liver disease: retrospective biopsy and necropsy study. J Clin Pathol 1986; 39: 63–67.
  • 45
    Wanless IR, Wong F, Blendis LM, Greig P, Heathcote EJ, Levy G. Hepatic and portal vein thrombosis in cirrhosis: possible role in development of parenchymal extinction and portal hypertension. Hepatology 1995; 21: 1238–1247.
  • 46
    Kelleher CC. Clinical aspects of the relationship between oral contraceptives and abnormalities of the hemostatic system: relation to the development of cardiovascular disease. Am J Obstet Gynecol 1990; 163: 392–395.
  • 47
    Florentin RA, Nam SC, Lee KT, Thomas WA. Increased 3H-thymidine incorporation into endothelial cells of swine fed cholesterol for 3 days. Exp Mol Pathol 1969; 10: 250–255.
  • 48
    Armstrong ML, Peterson RE, Hoak JC, Megan MB, Cheng FH, Clarke WR. Arterial platelet accumulation in experimental hypercholesterolemia. Atherosclerosis 1980; 36: 89–100.
  • 49
    Wanless IR. The effect of dietary cholesterol on platelet survival in the rabbit. A study using 14C-serotonin and 51-Chromium double labelled platelets. Thromb Haemost 1984; 52: 85–89.
  • 50
    Renaud S, Lecompte F. Hypercoagulability induced by hyperlipidemia in rat, rabbit and man. Role of platelet factor 3. Circ Res 1970; 27: 1003–1011.
  • 51
    Gresele P, Zoja C, Deckmyn H, Arnout J, Vermylen J, Verstraete M. Dipyridamole inhibits platelet aggregation in whole blood. Thromb Haemost 1983; 50: 852–856.
  • 52
    Fahr A, Langer R, Sziegoliet W, Beitz J, Krause P, Forster W. In vivo synthesis of prostacyclin-like substances in human varicose veins. Biomed Biochem Acta 1984; 43: K6–K8.
  • 53
    Dembinska-Kiec A, Rucker W, Schonhofer PS. Effects of dipyridamole in experimental atherosclerosis. Action on PGI2, platelet aggregation and atherosclerotic plaque formation. Atherosclerosis 1979; 33: 315–327.
  • 54
    Lautt WW. Relationship between hepatic blood flow and overall metabolism: the hepatic arterial buffer response. Fed Proc 1983; 42: 1662–1666.
  • 55
    Kuwano H, Yano K, Ohno S, Ikebe M, Kitamura K, Toh Y, Mori M. et al. Dipyridamole inhibits early wound healing in rat skin incisions. J Surg Res 1994; 56: 267–270.
  • 56
    Luliano L, Pratico D, Ghiselli A, Bonavita MS, Violi F. Reaction of dipyridamole with the hydroxyl radical. Lipids 1992; 27: 349–353.
  • 57
    Jablonska-Kaszewska I, Dabrowska E, Boj E, Baranowska B, Vogel M. Effect of dipyridaniole on liver changes during acute poisoning with carbon tetrachloride in rats. Pol Arch Med Wewn 1979; 62: 511–517.
  • 58
    Kast A, Nishikawa J, Yabe T. Decrease of carbon tetrachloride liver toxic-ity in rats given dipyridaniole. Exp Pathol 1982; 21: 123–133.
  • 59
    Perezalvarez V, Bobadillalugo RA, Muriel P, Favari L, Villanuevalopez C. Effects of leukotriene synthesis inhibition on acute liver damage induced by carbon tetrachloride. Pharmacology 1993; 7: 330–336.
  • 60
    Vissinger H, Husted SE, Kristensen SD, Nielsen HK. Dipyridaniole and platelet release of platelet-derived growth factor. Platelets 1994; 5: 105–108.
  • 61
    Breddin HK. Current perspectives in the antiplatelet therapy of thrombotic disorders. Semin Thromb Hemost 1989; 15: 144–149.
  • 62
    Suren A, Bauer FE, Rosenkranz B, Bircher J. Effect of pentoxifylline on liver plasma flow in normal man. Eur J Clin Pharmacol 1991; 41: 233–237.
  • 63
    Crouch SPM, Fletcher J. Effect of ingested pentoxifylline on neutrophil superoxide anion production. Infect Immun 1992; 60: 4504–4509.
  • 64
    Shulman HM, Hinterberger W. Hepatic veno-occlusive disease—liver toxicity syndrome after bone marrow transplantation. Bone Marrow Transplant 1992; 10: 197–214.
Get PDF (3437K)